Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06426797
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-23
First Post:
2024-05-19
Brief Title:
Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Organization Data
Organization:
Peking University Peoples Hospital
Class:
OTHER
Study ID:
AK104-IIT-C-N1-0104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Yang Fan MD
Responsible Party Title:
Professor of Thoracic Surgery
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking University Peoples Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Akeso Pharmaceuticals Inc | OTHER |